venetoclax news

All news on venetoclax (also known as Venclexta and Venclyxto): plants, production capacities, investments and involved companies.

14 June 2026

Lilly: Jaypirca plus venetoclax‑rituximab lowers progression risk 45% in relapsed/refractory CLL/SLL

Phase 3 BRUIN CLL-322 found adding pirtobrutinib to a two‑year venetoclax+rituximab regimen reduced progression or death by 45% versus venetoclax+rituximab alone.

Who will be producing venetoclax in the future?

Find out with chemXplore

Learn more